Philips adjusts earnings outlook after tariff relief, shares in S&P 500 peer focus
28.06.2026 - 12:30:09 | ad-hoc-news.de
By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-28, 12:29.
Philips (NL0000009538) refines its earnings outlook after an EU-US trade agreement reduced the expected impact of American import tariffs on its medical equipment portfolio. The Amsterdam-listed health technology group competes globally with S&P 500 names such as Medtronic and Abbott Laboratories in hospital and home-care devices, making tariff changes a concrete factor for cross-market investors. A recent market report on the Philips tariff adjustment
What the tariff revision changes
According to a recent sector summary, Philips previously estimated the gross impact of US import duties on its products at roughly $275 million for the period under review, based on an assumed 20 percent tariff rate on relevant shipments into the American market. Coverage of Philips' earlier tariff estimate The follow-up assessment after EU-US negotiations now indicates a total tariff impact of around $230 million, reflecting the agreed 15 percent levy and a corresponding easing of cost pressure compared with the initial scenario. Details on the 15 percent tariff agreement
In euro terms, Philips has communicated a revised range of 150 million to 200 million euros for the tariff effect on its profit and loss account, compared with an earlier April estimate of 250 million to 300 million euros under a 20 percent duty assumption on selected medical devices entering the US. Breakdown of the euro tariff impact range The reduction of roughly 100 million euros at the upper end of the range is meaningful for a group whose adjusted EBITA margin guidance sits in the low double-digit area and whose US exposure remains a major profit contributor.
Earnings guidance and sector comparison
Alongside the tariff revision, Philips reported second-quarter sales of about 4.3 billion euros, a 2.8 percent decrease compared with the prior-year quarter, underlining a muted top-line performance in a period of mixed demand for capital equipment and consumer health products. Summary of Philips' quarterly revenue Net profit in the same quarter fell by around 47 percent to 240 million euros, reflecting restructuring expenses and the tariff-related cost burden, while orders increased by 6 percent on a comparable basis when currency effects are stripped out, signaling support from longer-term contracts with hospitals and health systems. Data on Philips' net income and order growth
On the margin side, Philips lifted its adjusted EBITA guidance to a corridor between roughly 11.3 percent and 11.8 percent for the current year, helped by the lower expected tariff drag and internal efficiency programs aimed at streamlining manufacturing and overhead structures. Commentary on Philips' updated EBITA margin target For context, large US-listed medical equipment peers in the S&P 500, such as Medtronic and Abbott Laboratories, have historically targeted mid-teens operating margins, leaving Philips with some room to narrow the profitability gap through further savings and portfolio moves.
All news and analysis on the Philips shares
Further updates on Philips, from quarterly figures to analyst reports and sector comparisons, are gathered on the dedicated topic page and the company investor relations site.
The product behind the stock
Philips generates most of its revenue from health technology systems and devices, including patient monitoring platforms and imaging equipment for hospitals, as well as appliances for personal health. A concrete flagship line is its Philips IntelliVue patient monitoring system, which connects bedside monitors, central stations and software for continuous tracking of vital signs in intensive care and general ward environments.
Where the stock trades today
The Philips shares (NL0000009538) trade on the NYSE under the ticker PHG; as of 2026-06-26, 16:00 New York time, the last quoted price was 27.10 US dollars.
Key data on the Philips shares
- Company: Koninklijke Philips N.V.
- ISIN: NL0000009538
- WKN: 865528
- Ticker: PHG
- Trading venue: NYSE
- Price (as of 2026-06-26, 16:00): 27.10 USD
- Market cap: 24.5 billion USD (as of 2026-06-26)
- Sector / industry: Health Care Equipment & Supplies
- Index membership: Member of major European indices; not in the S&P 500
- Next earnings date: 2026-07-29
Disclaimer: This text is for informational purposes only and does not constitute investment advice, a buy or sell recommendation, or a solicitation to purchase any financial instrument. All data are based on sources deemed reliable but cannot be guaranteed; investors should conduct their own research or consult a professional advisor before making investment decisions.
